e-learning
resources
Munich 2006
Tuesday 05.09.2006
New findings in the immunology of COPD and interstitial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparison of the clinical features of lung cancer in chronic hypersensitivity pneumonitis (CHP) and in collagen vascular disease related interstitial pneumonitis (CVD-IP)
J. Kuramochi, Y. Ohtani, N. Inase, H. Kawachi, M. Tamaoka, M. Furuie, S. Isogai, Y. Miyazaki, T. Takemura, S. Saiki, Y. Yoshizawa (Tokyo, Japan)
Source:
Annual Congress 2006 - New findings in the immunology of COPD and interstitial lung diseases
Session:
New findings in the immunology of COPD and interstitial lung diseases
Session type:
Thematic Poster Session
Number:
3914
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Kuramochi, Y. Ohtani, N. Inase, H. Kawachi, M. Tamaoka, M. Furuie, S. Isogai, Y. Miyazaki, T. Takemura, S. Saiki, Y. Yoshizawa (Tokyo, Japan). Comparison of the clinical features of lung cancer in chronic hypersensitivity pneumonitis (CHP) and in collagen vascular disease related interstitial pneumonitis (CVD-IP). Eur Respir J 2006; 28: Suppl. 50, 3914
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Panel discussion on acute decompensated pulmonary hypertension
Related content which might interest you:
Comparison of registries of interstitial lung diseases in three European countries
Source: Eur Respir J 2001; 18: 114S-118S
Year: 2001
Small airways impairment and air-trapping distinguish chronic hypersensitivity pneumonitis (CHP) from idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
Pertechnegas lung clearance in different forms of interstitial lung disease
Source: Eur Respir J 2002; 19: 31-36
Year: 2002
Prognostic relevance of histologic features in nonspecific interstitial pneumonia (NSIP)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia
Source: International Congress 2015 – Treatment of IPF
Year: 2015
Comparison of clinical features between patients of lung cancer with combined pulmonary fibrosis and emphysema syndrome and those with interstitial pneumonia
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012
Inhibition of local fibrinolysis differs between idiopathic pulmonary fibrosis (IPF) and fibrotic non-specific interstitial pneumonia (f-NSIP)
Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms
Year: 2009
UIP-like or NSIP pattern in interstitial lung disease patients (ILD), following by ‘connective tissue disease ‘(CTD)
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012
Chronic hypersensitivity pneumonitis and its differential diagnosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=189
Year: 2007
Chronic hypersensitivity pneumonitis with familial history of interstitial lung disease
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
Comparison between the HRCT manifestations of thoracic involvement in collagen vascular diseases (CVD) and idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2001; 18: Suppl. 33, 225s
Year: 2001
Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Morphologic evaluation of lung in a scleroderma-like rabbit model
Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease
Year: 2006
Interstital lung diseases: update 2005
Source: Annual Congress 2005 - Clinical year in review
Year: 2005
Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP)
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Interstitial lung disease
Source: Eur Respir Rev 2013; 22: 26-32
Year: 2013
Characterization of interstitial pneumonia associated with clinical amyopathic dermatomyositis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept